申请人:Gilead Sciences, Inc.
公开号:US20160130275A1
公开(公告)日:2016-05-12
The invention provides compounds of Formula I or Formula II:
or a pharmaceutically acceptable salt or ester, thereof, as described herein. The compounds and compositions thereof are useful for treating Pneumovirinae virus infections. The compounds, compositions, and methods provided are particularly useful for the treatment of Human respiratory syncytial virus infections.
本发明提供了以下式子的化合物:或其药物可接受的盐或酯,如本文所述。该化合物及其组合物对于治疗Pneumovirinae病毒感染是有用的。所提供的化合物、组合物和方法特别适用于治疗人类呼吸道合胞病毒感染。